Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Sheri Bisby

Clinical Neurophysiology Wildwood, FL Medical Doctor

NPI 1851574065 CMS profile 175600

837 S Main St, Wildwood, FL 34785

Open in the dashboard

General payments

$5,514

291 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Sheri Bisby of Wildwood, FL is reported in the CMS Open Payments database as having received $5,514 across 291 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 69th percentile of Clinical Neurophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $16 1
2022 General $1,353 67
2021 General $2,149 105
2020 General $1,042 58
2019 General $955 60

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sheri Bisby
  • Clinical Neurophysiology median
  • Middle half of Clinical Neurophysiology
  • National median

In program year 2025, general payments to Sheri Bisby were reported at $16. Among 259 Clinical Neurophysiology profiles paid that year, the median was $435 and the middle half received between $121 and $1,917.

Show as a table
Year Sheri Bisby Clinical Neurophysiology median Middle half National median
2019 $955 $306 $88–$1,636 $163
2020 $1,042 $299 $85–$1,847 $114
2021 $2,149 $325 $96–$2,308 $132
2022 $1,353 $395 $106–$1,957 $149
2023 $0 $388 $120–$1,718 $160
2024 $0 $471 $137–$1,931 $164
2025 $16 $435 $121–$1,917 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. UCB, Inc. $688 23 payments
  2. AbbVie, Inc. $616 33 payments
  3. Amgen Inc. $604 30 payments
  4. Novartis Pharmaceuticals Corporation $337 21 payments
  5. Lundbeck LLC $317 15 payments
  6. Allergan Inc. $263 22 payments
  7. Janssen Pharmaceuticals, Inc $223 8 payments
  8. Genentech USA, Inc. $185 13 payments
  9. Alexion Pharmaceuticals, Inc. $168 7 payments
  10. Adamas Pharmaceuticals, Inc. $140 10 payments
  11. Other $1,972 109 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $5,330 286 payments
  2. Education $120 2 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $64 3 payments
Products named General payments · program years 2019–2025
  1. AIMOVIG $762 39 payments
  2. Vimpat $343 11 payments
  3. VYEPTI $317 15 payments
  4. DUOPA $269 14 payments
  5. Briviact $220 9 payments
  6. OCREVUS $185 13 payments
  7. NURTEC ODT $175 9 payments
  8. QULIPTA $174 9 payments
  9. UBRELVY $173 10 payments
  10. GOCOVRI $140 10 payments
  11. Other $2,485 139 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

291 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Neurophysiology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record